MACROGENICS INC — Director's Dealing 2022

May 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2022-05-19

Reporting Person: Ferrante Karen Jean (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-19	Stock Option (right to buy)	$3.9	A	18000	Acquired	2032-05-19	Common Stock (18000.0)	Direct
2022-05-19	Stock Option (right to buy)	$3.9	A	20640	Acquired	2032-05-19	Common Stock (20640.0)	Direct

Footnotes

F1: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

F2: At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.